168 related articles for article (PubMed ID: 37978394)
1. Pediatric pulmonary multisystem langerhans cell histiocytosis: does lung lesion severity affect the outcome?
Sedky M; Gohar S; Ahmed S; Zaky I; Salama A; Hassanein O; Maher E; ElHaddad A
Orphanet J Rare Dis; 2023 Nov; 18(1):361. PubMed ID: 37978394
[TBL] [Abstract][Full Text] [Related]
2. [Clinical manifestations of Langerhans cell histiocytosis with multisystem involvement in 53 children].
Tang JJ; Xu XJ; Wang YC; Bai ST; Wang L; Ni XL; Liu YF
Zhonghua Er Ke Za Zhi; 2021 Jan; 59(1):37-41. PubMed ID: 33397002
[No Abstract] [Full Text] [Related]
3. Clinical and prognostic characteristics of 95 cases of Langerhans cell histiocytosis in children: a single-institute experience from 2013 to 2020.
Tang X; Gao J; Ma ZG; Guo X; Li Q; Wan Z; Sun JJ
Ann Med; 2021 Dec; 53(1):1537-1546. PubMed ID: 34459688
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes and screening for organ involvement in pediatric Langerhans cell histiocytosis in Thailand: multicenter study on behalf of the Thai Pediatric Oncology Group.
Monsereenusorn C; Suwannaying K; Techavichit P; Sathitsamitphong L; Komvilaisak P; Rujkijyanont P; Seksarn P; Charoenkwan P; Pakakasama S
Int J Hematol; 2022 Apr; 115(4):563-574. PubMed ID: 35099760
[TBL] [Abstract][Full Text] [Related]
5. Egyptian experience in Langerhans cells histiocytosis: frequent multisystem affection and reactivation rates.
Tantawy AAG; Ragab IA; Elsherif NHK; Makkeyah SM; AbdelRaheem HG; Elsantiel HIE
Pediatr Hematol Oncol; 2020 Nov; 37(8):696-706. PubMed ID: 32706277
[No Abstract] [Full Text] [Related]
6. Additive Prognostic Impact of Gastrointestinal Involvement in Severe Multisystem Langerhans Cell Histiocytosis.
Minkov M; Pötschger U; Thacker N; Astigarraga I; Braier J; Donadieu J; Henter JI; Lehrnbecher T; Rodriguez-Galindo C; Sieni E; Nanduri V; van den Bos C; Abla O;
J Pediatr; 2021 Oct; 237():65-70.e3. PubMed ID: 34146548
[TBL] [Abstract][Full Text] [Related]
7. Outcome of High-risk Langerhans Cell Histiocytosis (LCH) in Egyptian Children, Does Intermediate-dose Methotrexate Improve the Outcome?
Sedky MS; Hamouda A; Taha H; Zaky I; Hassanain O; El Hemaly A; ElHaddad A
J Pediatr Hematol Oncol; 2019 Nov; 41(8):635-643. PubMed ID: 30247183
[TBL] [Abstract][Full Text] [Related]
8. Clinical presentation and prognostic analysis of adult patients with Langerhans cell histiocytosis with pulmonary involvement.
Miao HL; Zhao AL; Duan MH; Zhou DB; Cao XX; Li J
BMC Cancer; 2020 Sep; 20(1):911. PubMed ID: 32967635
[TBL] [Abstract][Full Text] [Related]
9. Lack of bone lesions at diagnosis is associated with inferior outcome in multisystem langerhans cell histiocytosis of childhood.
Aricò M; Astigarraga I; Braier J; Donadieu J; Gadner H; Glogova E; Grois N; Henter JI; Janka G; McClain KL; Ladisch S; Pötschger U; Rosso D; Thiem E; Weitzman S; Windebank K; Minkov M;
Br J Haematol; 2015 Apr; 169(2):241-8. PubMed ID: 25522229
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary involvement in pediatric-onset multisystem Langerhans cell histiocytosis: effect on course and outcome.
Ronceray L; Pötschger U; Janka G; Gadner H; Minkov M;
J Pediatr; 2012 Jul; 161(1):129-33.e1-3. PubMed ID: 22284564
[TBL] [Abstract][Full Text] [Related]
11. Craniofacial involvement in Langerhans cell histiocytosis: A review of 44 cases at a single medical center.
Lin TE; Chu YY; Chang TY; Liao HT
J Plast Reconstr Aesthet Surg; 2023 Jul; 82():12-20. PubMed ID: 37148805
[TBL] [Abstract][Full Text] [Related]
12.
Obert J; Vercellino L; Van Der Gucht A; de Margerie-Mellon C; Bugnet E; Chevret S; Lorillon G; Tazi A
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):598-610. PubMed ID: 27645693
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: Results from the BCH-LCH 2014 protocol study.
Cui L; Wang CJ; Lian HY; Zhang L; Ma HH; Wang D; Chen FF; Zhang Q; Yang Y; Wei A; Huang XT; Zhu T; Wang TY; Li ZG; Zhang R
Am J Hematol; 2023 Apr; 98(4):598-607. PubMed ID: 36594188
[TBL] [Abstract][Full Text] [Related]
14. Clinical Research of Pulmonary Langerhans Cell Histiocytosis in Children.
Wang D; Cui L; Li ZG; Zhang L; Lian HY; Ma HH; Zhao YZ; Zhao XX; Wang TY; Zhang R
Chin Med J (Engl); 2018 Aug; 131(15):1793-1798. PubMed ID: 30058575
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis.
Cao XX; Duan MH; Zhao AL; Cai H; Chen J; Gao XM; Liu T; Cai HC; Zhang L; Sun J; Liang ZY; Zhou DB; Li J
Am J Hematol; 2022 Feb; 97(2):203-208. PubMed ID: 34797941
[TBL] [Abstract][Full Text] [Related]
16. Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival.
Hazim AZ; Ruan GJ; Hu M; Ravindran A; Rech KL; Young JR; Cox CW; Abeykoon JP; Scheckel C; Vassallo R; Ryu JH; Tobin WO; Koster MJ; Bennani NN; Shah MV; Goyal G; Go RS;
Am J Hematol; 2021 Dec; 96(12):1604-1610. PubMed ID: 34553412
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood.
Odame I; Li P; Lau L; Doda W; Noseworthy M; Babyn P; Weitzman S
Pediatr Blood Cancer; 2006 Dec; 47(7):889-93. PubMed ID: 16276522
[TBL] [Abstract][Full Text] [Related]
18. Langerhans cell histiocytosis in adolescent patients: a single-centre retrospective study.
Cai HC; Chen J; Liu T; Cai H; Duan MH; Li J; Zhou DB; Cao XX
Orphanet J Rare Dis; 2022 Jul; 17(1):268. PubMed ID: 35841042
[TBL] [Abstract][Full Text] [Related]
19. Intensification of treatment with vinca alkaloid does not improve outcomes in pediatric patients with Langerhans cell histiocytosis: results from the JPLSG LCH-12 study.
Morimoto A; Shioda Y; Kudo K; Kanegane H; Imamura T; Koh K; Kosaka Y; Yuza Y; Nakazawa A; Saito AM; Watanabe T; Nakazawa Y
Int J Hematol; 2023 Jul; 118(1):107-118. PubMed ID: 36871086
[TBL] [Abstract][Full Text] [Related]
20. Childhood Langerhans cell histiocytosis with severe lung involvement: a nationwide cohort study.
Le Louet S; Barkaoui MA; Miron J; Galambrun C; Aladjidi N; Chastagner P; Kebaili K; Armari-Alla C; Lambilliotte A; Lejeune J; Moshous D; Della Valle V; Sileo C; Ducou Le Pointe H; Chateil JF; Renolleau S; Piloquet JE; Portefaix A; Epaud R; Chiron R; Bugnet E; Lorillon G; Tazi A; Emile JF; Donadieu J; Héritier S
Orphanet J Rare Dis; 2020 Sep; 15(1):241. PubMed ID: 32907615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]